ATP13A5
Probable cation-transporting ATPase 13A5
Also known as: AT135_HUMAN, FLJ16025
Cross-references: UniProt · Ensembl · Human Protein Atlas · GeneCards · NCBI Gene
Protein identityUniProt · HPA
- UniProt accession
- Q4VNC0
- Gene
- ATP13A5
- Ensembl
- ENSG00000187527
- Chromosome
- 3
- Canonical length
- 1218 aa
- Protein class
- Predicted membrane proteins
- Subcellular location
- Nucleoplasm,Plasma membrane
OverviewNCBI Gene
This gene encodes a member of the P5 subfamily of P-type transport ATPases. P-type ATPases form a large superfamily of cation and lipid pumps that transport inorganic cations and other substrates across cell membranes. P5 ATPases are localized to membranes of the endoplasmic reticulum (ER) and serve many important functions including transport of cargo proteins to the Golgi, glycosylation and cell wall biosynthesis, control of protein insertion orientation, 3-hydroxy-3-methylglutaryl-CoA reductase (HMGR) degradation, and sensitivity to unfolded protein response (UPR) activators. The encoded protein is organized into three cytoplasmic domains (A, P, and N) and two membrane-embedded domains (T and S). The N-domain binds ATP and serves as a built-in protein kinase, which phosphorylates the P-domain. The A-domain is an intrinsic protein phosphatase, which dephosphorylates the P-domain once during each catalytic cycle. [provided by RefSeq, Jul 2017]
Canonical amino-acid sequenceUniProt
1218 residues, UniProt reviewed canonical sequence.
>Q4VNC0|ATP13A5
1 MEENSKKDHR ALLNQGEEDE LEVFGYRDHN VRKAFCLVAS VLTCGGLLLV FYWRPQWRVW
61 ANCIPCPLQE ADTVLLRTTD EFQRYMRKKV FCLYLSTLKF PVSKKWEESL VADRHSVINQ
121 ALIKPELKLR CMEVQKIRYV WNDLEKRFQK VGLLEDSNSC SDIHQTFGLG LTSEEQEVRR
181 LVCGPNAIEV EIQPIWKLLV KQVLNPFYVF QAFTLTLWLS QGYIEYSVAI IILTVISIVL
241 SVYDLRQQSV KLHNLVEDHN KVQVTIIVKD KGLEELESRL LVPGDILILP GKFSLPCDAV
301 LIDGSCVVNE GMLTGESIPV TKTPLPQMEN TMPWKCHSLE DYRKHVLFCG TEVIQVKPSG
361 QGPVRAVVLQ TGYNTAKGDL VRSILYPRPL NFKLYSDAFK FIVFLACLGV MGFFYALGVY
421 MYHGVPPKDT VTMALILLTV TVPPVLPAAL TIGNVYAQKR LKKKKIFCIS PQRINMCGQI
481 NLVCFDKTGT LTEDGLDLWG TVPTADNCFQ EAHSFASGQA VPWSPLCAAM ASCHSLILLN
541 GTIQGDPLDL KMFEGTAWKM EDCIVDSCKF GTSVSNIIKP GPKASKSPVE AIITLCQFPF
601 SSSLQRMSVI AQLAGENHFH VYMKGAPEMV ARFCRSETVP KNFPQELRSY TVQGFRVIAL
661 AHKTLKMGNL SEVEHLAREK VESELTFLGL LIMENRLKKE TKLVLKELSE ARIRTVMITG
721 DNLQTAITVA KNSEMIPPGS QVIIVEADEP EEFVPASVTW QLVENQETGP GKKEIYMHTG
781 NSSTPRGEGG SCYHFAMSGK SYQVIFQHFN SLLPKILVNG TVFARMSPGQ KSSLIEEFQK
841 LNYYVGMCGD GANDCGALKA AHAGISLSEQ EASVASPFTS KTTNIQCVPH LIREGRAALV
901 SSFGVFKYLT MYGIIQFISA LLLYWQLQLF GNYQYLMQDV AITLMVCLTM SSTHAYPKLA
961 PYRPAGQLLS PPLLLSIFLN SCFSCIVQIS AFLYVKQQPW YCEVYQYSEC FLANQSNFST
1021 NVSLERNWTG NATLIPGSIL SFETTTLWPI TTINYITVAF IFSKGKPFRK PIYTNYIFSF
1081 LLLAALGLTI FILFSDFQVI YRGMELIPTI TSWRVLILVV ALTQFCVAFF VEDSILQNHE
1141 LWLLIKREFG FYSKSQYRTW QKKLAEDSTW PPINRTDYSG DGKNGFYING GYESHEQIPK
1201 RKLKLGGQPT EQHFWARLLocalizationUniProt · AlphaFold · HPA
Whether an antibody against ATP13A5 can act on the native protein depends on physical access: surface and secreted proteins are reachable by circulating antibodies, intracellular proteins usually are not.
- Antibody reachability
- Cell surface
- Secreted
- No
- Transmembrane segments
- 10
- Mean surface accessibility (rSASA)
- 0.27
- Highest tissue expression
- 33 nTPM
Expression across tissuesHPA
Tissue
- choroid plexus: 33 nTPM
- breast: 16 nTPM
- salivary gland: 11 nTPM
- skin: 2.7 nTPM
- stomach: 1.4 nTPM
- skeletal muscle: 1.2 nTPM
Single-cell type
- choroid plexus epithelial cells: 359 nCPM
- astrocytes: 64 nCPM
- cone photoreceptor cells: 37 nCPM
- foveolar cells: 36 nCPM
- oligodendrocyte progenitor cells: 33 nCPM
- bergmann glia: 31 nCPM
Immune cell
- neutrophil: 1 nTPM
- basophil: 0.1 nTPM
- eosinophil: 0.1 nTPM
- naive B-cell: 0.1 nTPM
- plasmacytoid DC: 0.1 nTPM
- classical monocyte: 0 nTPM
Brain region
- choroid plexus: 82 nTPM
- hippocampal formation: 6.8 nTPM
- thalamus: 5.7 nTPM
- midbrain: 5.1 nTPM
- amygdala: 4.9 nTPM
- basal ganglia: 4.6 nTPM
Genetic constraint and essentialitygnomAD · DepMap
Does the body need this protein intact? Low LOEUF or a strong DepMap dependency means loss or blockade of the protein is likely to be felt.
- gnomAD LOEUF (loss-of-function intolerance)
- 1.29
- gnomAD pLI
- 0
- gnomAD missense Z
- 0.61
- DepMap mean gene effect
- 0.09
- DepMap dependency class
- none
Cancer expressionTCGA
Across TCGA tumor cohorts, this protein is over-expressed in roughly 4% of surveyed tumor types (aggregate summary; per-cohort expression, alteration, and survival load in the interactive view).
OntologyGO
Biological processes
- intracellular calcium ion homeostasis
- monoatomic ion transmembrane transport
- polyamine transmembrane transport
Molecular functions
- ATP binding
- ATP hydrolysis activity
- ATPase-coupled monoatomic cation transmembrane transporter activity
- metal ion binding
- P-type ion transporter activity
- polyamine transmembrane transporter activity
Cellular components
Protein domainsUniProt · Pfam · InterPro
- P-type ATPase
- Cation-transporting P-type ATPase, N-terminal
- P-type ATPase, subfamily V
- P-type ATPase, A domain superfamily
- P-type ATPase, phosphorylation site
- HAD superfamily
- P-type ATPase, transmembrane domain superfamily
- P-type ATPase, cytoplasmic domain N
- HAD-like superfamily
- P-type ATPase, haloacid dehalogenase domain
- P5B-type ATPase, N-terminal
- P5B-type ATPase
- P-type ATPase, A domain
- P-type ATPase actuator domain
- Cation transporter/ATPase, N-terminus
- P5-type ATPase cation transporter
- P-type ATPase, cytoplasmic domain N
KeywordsUniProt
Antibody and autoantibody relevanceSeroatlas analysis
Seroatlas reads ATP13A5 as an antibody target. Whether an autoantibody or antibody against ATP13A5 could matter depends on whether native ATP13A5 is physically reachable, whether the body needs it intact, and whether it acts in a disease-relevant tissue.
ATP13A5 is annotated at the cell surface, where native ATP13A5 is exposed to circulating antibodies and is a prime autoantibody target that could block, deplete, or overstimulate it.
Annotation status
The present source text does not explicitly label ATP13A5 as an autoantigen. Seroatlas presents hypothesis context only and does not manufacture a known-serology claim.
Loading the interactive Seroatlas protein explorer...